BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
BIOMERICA INC
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026
$1.76−0.09 (-4.86%)
Close on Oct 19, 2026
- Market cap
- $5.80M
- P/E (TTM)
- –
- Dividend yield
- –
BIOMERICA INC revenue by segment
By business segment
By product or service
| Revenue | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Lab [Member] | $2.73M | $2.82M | $2.83M | $2.93M | $3.18M | $3.24M | $3.01M | $3.23M | $3.24M | $3.42M | $3.54M | $3.45M | 61.4% | -14.1% |
| Contract Manufacturing [Member] | $891.00K | $681.00K | $834.00K | $922.00K | $1.07M | $1.13M | $1.09M | $962.00K | $741.00K | $708.00K | $711.00K | $632.00K | 20.0% | -16.7% |
| Over-The-Counter [Member] | $821.00K | – | – | – | $1.05M | – | – | $1.31M | $1.43M | $1.27M | $1.24M | $1.26M | 18.4% | -21.7% |
| Physician's office [Member] | $9.00K | $10.00K | $10.00K | $12.00K | $11.00K | $12.00K | $13.00K | $11.00K | $12.00K | $9.00K | $9.00K | $70.00K | 0.2% | -18.2% |
By region
| Revenue | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America [Member] | $1.47M | $1.30M | $1.44M | $1.55M | $1.66M | $1.60M | $1.59M | $1.36M | $1.29M | $1.41M | $1.48M | $1.56M | 32.9% | -11.6% |
| Asia [Member] | $1.41M | $1.40M | $1.50M | $1.57M | $1.72M | $1.65M | $1.50M | $1.67M | $1.88M | $2.04M | $2.18M | $2.23M | 31.6% | -18.0% |
| Europe [Member] | $1.12M | $1.17M | $1.08M | $1.13M | $1.30M | $1.33M | $1.47M | $1.58M | $1.44M | $1.62M | $1.59M | $1.57M | 25.1% | -13.9% |
| Middle East [Member] | $446.00K | $443.00K | $421.00K | $625.00K | $630.00K | $1.09M | $1.02M | $889.00K | $800.00K | – | – | – | 10.0% | -29.2% |
| South America [Member] | $15.00K | $12.00K | $15.00K | $7.00K | $8.00K | $8.00K | $10.00K | $9.00K | $11.00K | $11.00K | $10.00K | $12.00K | 0.3% | +87.5% |
From the segment and revenue-disaggregation notes of Biomerica's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.